These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 21212911
1. Desogestrel+ethinylestradiol versus levonorgestrel+ethinylestradiol. Which one has better affect on acne, hirsutism, and weight change. Sanam M, Ziba O. Saudi Med J; 2011 Jan; 32(1):23-6. PubMed ID: 21212911 [Abstract] [Full Text] [Related]
2. Effects of second and third generation oral contraceptives and their respective progestagens on the coagulation system in the absence or presence of the factor V Leiden mutation. Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE. Thromb Haemost; 2002 Feb; 87(2):199-205. PubMed ID: 11859850 [Abstract] [Full Text] [Related]
3. Increased fibrinolytic activity during use of oral contraceptives is counteracted by an enhanced factor XI-independent down regulation of fibrinolysis: a randomized cross-over study of two low-dose oral contraceptives. Meijers JC, Middeldorp S, Tekelenburg W, van den Ende AE, Tans G, Prins MH, Rosing J, Büller HR, Bouma BN. Thromb Haemost; 2000 Jul; 84(1):9-14. PubMed ID: 10928462 [Abstract] [Full Text] [Related]
4. Efficacy of second versus third generation oral contraceptives in the treatment of hirsutism. Breitkopf DM, Rosen MP, Young SL, Nagamani M. Contraception; 2003 May; 67(5):349-53. PubMed ID: 12742556 [Abstract] [Full Text] [Related]
5. A randomized cross-over study on the effects of levonorgestrel- and desogestrel-containing oral contraceptives on the anticoagulant pathways. Tans G, Curvers J, Middeldorp S, Thomassen MC, Meijers JC, Prins MH, Bouma BN, Büller HR, Rosing J. Thromb Haemost; 2000 Jul; 84(1):15-21. PubMed ID: 10928463 [Abstract] [Full Text] [Related]
6. Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study. Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Thromb Haemost; 2000 Jul; 84(1):4-8. PubMed ID: 10928461 [Abstract] [Full Text] [Related]
7. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations. Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729 [Abstract] [Full Text] [Related]
8. [The effect of contraceptive with 20 ug ethinylestradiol and 150 ug desogestrel on some acute phase proteins]. Uchikova E, Batashki I, Milchev N, Mateva N, Markova D, Gŭrova A. Akush Ginekol (Sofiia); 2006 Apr; 45(2):39-43. PubMed ID: 16637303 [Abstract] [Full Text] [Related]
9. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne. Palatsi R, Reinilä M, Kivinén S. Acta Derm Venereol; 1986 Apr; 66(3):225-30. PubMed ID: 2426899 [Abstract] [Full Text] [Related]
10. A large observational clinical evaluation of a desogestrel-containing combiphasic oral contraceptive in Germany. Vree ML, Schmidt J. Eur J Contracept Reprod Health Care; 2001 Jun; 6(2):108-14. PubMed ID: 11518448 [Abstract] [Full Text] [Related]
11. Comparison of the effect on acne with a combiphasic desogestrel-containing oral contraceptive and a preparation containing cyproterone acetate. Vartiainen M, de Gezelle H, Broekmeulen CJ. Eur J Contracept Reprod Health Care; 2001 Mar; 6(1):46-53. PubMed ID: 11334476 [Abstract] [Full Text] [Related]
13. [A combiphasic oral contraceptive containing ethinylestradiol and desogestrel]. Poulsen HK. Ugeskr Laeger; 1995 Aug 07; 157(32):4473-5. PubMed ID: 7483033 [No Abstract] [Full Text] [Related]
14. The effects of desogestrel and ethinylestradiol combination in normal and hyperandrogenic young girls: speculations on contraception in adolescence. Venturoli S, Porcu E, Gammi L, Fabbri R, Paradisi R, Flamigni C, Patrono D, Capelli M, Paoletti C. Acta Eur Fertil; 1988 Aug 07; 19(3):129-34. PubMed ID: 2976224 [Abstract] [Full Text] [Related]
15. Effect of oral contraceptive containing ethinyl estradiol combined with drospirenone vs. desogestrel on clinical and biochemical parameters in patients with polycystic ovary syndrome. Kriplani A, Periyasamy AJ, Agarwal N, Kulshrestha V, Kumar A, Ammini AC. Contraception; 2010 Aug 07; 82(2):139-46. PubMed ID: 20654754 [Abstract] [Full Text] [Related]
16. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch. Jick SS, Jick H. Contraception; 2006 Oct 07; 74(4):290-2. PubMed ID: 16982227 [Abstract] [Full Text] [Related]
17. A comparison between monophasic levonorgestrel-ethinyl estradiol 150/30 and triphasic levonorgestrel-ethinyl estradiol 50-75-125/30-40-30 contraceptive pills for side effects and patient satisfaction: a study in Iran. Kashanian M, Shahpourian F, Zare O. Eur J Obstet Gynecol Reprod Biol; 2010 May 07; 150(1):47-51. PubMed ID: 20185226 [Abstract] [Full Text] [Related]
18. Comparison profiles of cycle control, side effects and sexual satisfaction of three hormonal contraceptives. Sabatini R, Cagiano R. Contraception; 2006 Sep 07; 74(3):220-3. PubMed ID: 16904415 [Abstract] [Full Text] [Related]
19. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 microg ethinylestradiol. Winkler UH, Ferguson H, Mulders JA. Contraception; 2004 Jun 07; 69(6):469-76. PubMed ID: 15157791 [Abstract] [Full Text] [Related]
20. [Effect of hormonal contraceptives containing 0.05 mg ethinyl estradiol and 0.125 mg desogestrel in normophasic regimen (Oviol)]. Weijers MJ. Fortschr Med; 1982 Apr 29; 100(16):764-7. PubMed ID: 6211403 [Abstract] [Full Text] [Related] Page: [Next] [New Search]